Literature DB >> 32807001

Impaired response of cerebral oxygen metabolism to visual stimulation in Huntington's disease.

Peter Klinkmueller1,2,3, Martin Kronenbuerger4,5,6, Xinyuan Miao2,3, Jee Bang4,5, Kia E Ultz4, Adrian Paez2,3, Xiaoyu Zhang2,3, Wenzhen Duan5,7, Russell L Margolis5,8, Peter Cm van Zijl2,3, Christopher A Ross5,7,8, Jun Hua2,3.   

Abstract

Huntington's disease (HD) is a neurodegenerative disease caused by a CAG triplet repeat expansion in the Huntingtin gene. Metabolic and microvascular abnormalities in the brain may contribute to early physiological changes that subserve the functional impairments in HD. This study is intended to investigate potential abnormality in dynamic changes in cerebral blood volume (CBV) and cerebral blood flow (CBF), and cerebral metabolic rate of oxygen (CMRO2) in the brain in response to functional stimulation in premanifest and early manifest HD patients. A recently developed 3-D-TRiple-acquisition-after-Inversion-Preparation magnetic resonance imaging (MRI) approach was used to measure dynamic responses in CBV, CBF, and CMRO2 during visual stimulation in one single MRI scan. Experiments were conducted in 23 HD patients and 16 healthy controls. Decreased occipital cortex CMRO2 responses were observed in premanifest and early manifest HD patients compared to controls (P < 0.001), correlating with the CAG-Age Product scores in these patients (R2 = 0.4, P = 0.001). The results suggest the potential value of this reduced CMRO2 response during visual stimulation as a biomarker for HD and may illuminate the role of metabolic alterations in the pathophysiology of HD.

Entities:  

Keywords:  Neurovascular; biomarker; imaging; neurodegeneration; ultra-high field

Year:  2020        PMID: 32807001      PMCID: PMC8054727          DOI: 10.1177/0271678X20949286

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  81 in total

1.  Sustained poststimulus elevation in cerebral oxygen utilization after vascular recovery.

Authors:  Hanzhang Lu; Xavier Golay; James J Pekar; Peter C M Van Zijl
Journal:  J Cereb Blood Flow Metab       Date:  2004-07       Impact factor: 6.200

2.  Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Authors:  Sarah J Tabrizi; Ralf Reilmann; Raymund A C Roos; Alexandra Durr; Blair Leavitt; Gail Owen; Rebecca Jones; Hans Johnson; David Craufurd; Stephen L Hicks; Christopher Kennard; Bernhard Landwehrmeyer; Julie C Stout; Beth Borowsky; Rachael I Scahill; Chris Frost; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2011-12-02       Impact factor: 44.182

3.  Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease.

Authors:  Robert C Wolf; Georg Grön; Fabio Sambataro; Nenad Vasic; Nadine D Wolf; Philipp A Thomann; Carsten Saft; G Bernhard Landwehrmeyer; Michael Orth
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

4.  Calibrated functional MRI: mapping the dynamics of oxidative metabolism.

Authors:  T L Davis; K K Kwong; R M Weisskoff; B R Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  A three-dimensional single-scan approach for the measurement of changes in cerebral blood volume, blood flow, and blood oxygenation-weighted signals during functional stimulation.

Authors:  Ying Cheng; Qin Qin; Peter C M van Zijl; James J Pekar; Jun Hua
Journal:  Neuroimage       Date:  2016-12-29       Impact factor: 6.556

6.  Whole-brain three-dimensional T2-weighted BOLD functional magnetic resonance imaging at 7 Tesla.

Authors:  Jun Hua; Qin Qin; Peter C M van Zijl; James J Pekar; Craig K Jones
Journal:  Magn Reson Med       Date:  2013-12-12       Impact factor: 4.668

7.  Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy.

Authors:  B G Jenkins; W J Koroshetz; M F Beal; B R Rosen
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

8.  Inflow-based vascular-space-occupancy (iVASO) MRI.

Authors:  Jun Hua; Qin Qin; Manus J Donahue; Jinyuan Zhou; James J Pekar; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2011-02-24       Impact factor: 4.668

Review 9.  Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.

Authors:  Susan E Browne
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Oxygen consumption deficit in Huntington disease mouse brain under metabolic stress.

Authors:  Song Lou; Victoria C Lepak; Lynn E Eberly; Brian Roth; Weina Cui; Xiao-Hong Zhu; Gülin Öz; Janet M Dubinsky
Journal:  Hum Mol Genet       Date:  2016-05-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.